Cumberland Pharmaceuticals

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$13,678
$8,292
$10,837
$11,713
Gross Profit
11,437
7,303
8,825
10,287
EBITDA
47
-795
699
2,734
EBIT
-1,279
-1,833
-619
1,417
Net Income
-1,411
-1,940
-740
1,257
Net Change In Cash
13,678
8,292
10,837
11,713
Free Cash Flow
3
163
817
3,850
Cash
11,444
15,196
16,087
15,108
Basic Shares
14,956
14,953
14,960
15,259

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$44,521
$37,867
$39,552
$42,010
Gross Profit
37,854
31,281
33,485
32,892
EBITDA
2,493
182
2,485
332
EBIT
-2,791
-5,860
-5,617
-4,995
Net Income
-2,836
-6,479
-6,279
-5,570
Net Change In Cash
44,521
37,867
39,552
42,010
Free Cash Flow
4,834
-791
5,640
6,379
Cash
11,444
17,964
18,321
19,757
Basic Shares
14,956
14,060
14,298
14,563

Earnings Calls

QuarterEPS
2026-03-31
$0
2025-12-31
-$0.09
2025-09-30
-$0.12
2025-06-30
-$0.05